State Street Corporation »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by State Street Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by State Street Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 22M 0.94
2023-12-31 $23M 23M 0.99
2023-09-30 $22M 23M 0.93

More positions owned by State Street Corporation

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Broadcom (AVGO)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Visa Com Cl A (V)

View all positions for State Street Corporation

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Lazard Asset Management
Calamos Advisors
Invesco
Advent Capital Management
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Wellington Management Company
State Street Corporation

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1